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Available online 24 September 2008The complexities of aortic dissection remain a major
challenge, with one of the highest mortality rates in
cardiovascular medicine. Surgical resection and interposi-
tion of vascular prostheses have long been considered the
standard treatment for type B dissection, despite the
substantial risk of severe complications from its invasive
approach, in an often aged population with inherent
co-morbidities.
Introduced a decade ago, the use of stent-graft has
progressively been recognised as a potential, revolutionary
alternative for treating descending aortic dissection both in
acute and chronic patients. The concept of endovascular
treatment in aortic dissection was based on the concept to
induce a positive aortic remodelling, by the closure of entry
sites resulting in complete false lumen thrombosis. In
recent years, there has been a progressive increase in the
number of interventional procedures, and a large number
of publications detailing subsequent outcomes have resul-
ted. Although initial reports were encouraging, randomized
data and long-term information clearly demonstrating
a substantial durability of the aortic remodelling and
a better survival for patients treated with stent-grafts have
not been provided yet. Second, an additional problem
regarding literature addressing stent-graft treatment in
aortic dissection is the lack of standardization. Acute and
chronic patients were treated with different indications
and different anatomical conditions. In acute patients signs
of malperfusion and aortic rupture, such as refractory
hypertension and persistent pain, are generally acceptedE-mail address: rossella.fattori@unibo.it
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doi:10.1016/j.ejvs.2008.09.005indication to treatment. However, thoracic pain and
hypertension are very broad clinical signs and can accom-
modate virtually any situation. Indication to treatment in
chronic dissection is usually based on a millimetric variation
of aortic diameter, assessed with different imaging
modalities and different methods, entailing an intrinsic risk
of over- or underestimation. Absolute diameters of the
descending aorta are usually not related to body surface
area,1 which is demonstrated to be an important determi-
nant of the aortic diameter. During follow-up, aortic
measurements, which are the only proofs of the success of
the procedures, are undertaken without standardized
criteria, often in axial images, which might not be repre-
sentative of the aortic remodelling process, carrying the
risk of partial volume errors.
In this issue of the Journal, Sayer and colleagues2 report
outcome data of patients treated with stent-graft for acute
and chronic aortic dissection, focusing on mid-term aortic
remodelling. Positive aortic remodelling induced by stent-
graft is an important morphological predictor of procedural
technical success, which is a prerequisite for clinical
success The authors measured both total aortic diameter
and the diameter of the false lumen alone at multiple levels
in the aorta. Aortic diameters were measured at 7 different
levels of the thoracic and abdominal aorta comparing true
lumen expansion, false lumen thrombosis and shrinkage in
acute and chronic dissection. At 30 months, while acute
patients seem to present a positive aortic remodelling,
chronic dissection do not. In particular the majority of
patients with chronic aortic dissection presented an aortic
expansion over the time, with low percentage (below 50%)
of false lumen thrombosis, and several of them requiredd by Elsevier Ltd. All rights reserved.
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this subgroup of patients was extremely meagre, 66.5%,
lower than standard survival rate with medical therapy3 or
in other series with endovascular stent-graft.4 Indeed, very
few patients even in the acute dissection group presented
a reduced aortic diameter after stent-graft, as the bar
graphs show, and 8/28 required a secondary intervention.
These disappointing results could lead to e maybe unjus-
tified e scepticism with regard to the utility of such
procedure in this delicate disease. However this study is
a good example of the challenges we are facing
approaching aortic dissection without standardized guide-
lines. Unfortunately no information regarding the position
and the number of entry sites is provided, therefore it is
difficult to understand if the low incidence of false lumen
thrombosis and shrinkage in chronic dissection as well as
the high number of reinterventions in acute cases were due
to failure to closure of entry and re-entries, which is the
first goal of the procedure. Moreover the heterogeneity of
the population (penetrating ulcers and intramural hema-
toma were mixed to classic dissection cases) renders diffi-
cult to generalize these results to all cases of aortic
dissection.
After 10 years from the first description of stent-graft in
aortic dissection5 we are still uncertain about the road ahead.
Preliminary results of randomized trials did not show any
survival benefit for stent-graft versus bestmedical therapy and
case series and observational studies fail to identify any
conclusion, because of the lack of standardized criteria for
indication to treatment, interventional technique and post-
operative care. Surgeons and Interventionists were allowed to
treat aortic dissection according to their own philosophywithout any control, with some centers sporadically venturing
into this complex disease without any adequate knowledge. As
a result, the black survival of patients with descending aortic
dissection seems do not improve.
However, any reported experience can serve as a good
foundation to address the steps to establish standardized
approaches in this growing field. Scrupulously designed
clinical trials must be performed to definitively determine
long-term results of these procedures as compared with the
gold standard of medical therapy and open surgical repair,
as well as to define the appropriate patient population that
will benefit the most.References
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